Want to join the conversation?
$SLB 2Q15 Q&A: Sedita of UBS asked about views on International E&P CapEx. Paal replied that it's too early to make predictions for 2016 and Company is relatively confident in tightening of the supply-demand balance for 2H15. Even if there is an improvement in oil prices, it won't be a huge impact on 2015 budget, but good chance for growth in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.